Sweden
· Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 21.73 billion. The enterprise value is 21.27 billion.
| Market Cap | 21.73B |
| Enterprise Value | 21.27B |
Important Dates
The last earnings date was Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioArctic AB has 88.39 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 88.39M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 33.78% |
| Owned by Institutions (%) | 49.22% |
| Float | 52.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.41 |
| PS Ratio | 84.57 |
| PB Ratio | 24.28 |
| P/TBV Ratio | 24.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -120.10 |
| EV / Sales | 82.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.75 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -122.16 |
Financial Efficiency
Return on equity (ROE) is -18.24% and return on invested capital (ROIC) is -14.11%.
| Return on Equity (ROE) | -18.24% |
| Return on Assets (ROA) | -12.29% |
| Return on Invested Capital (ROIC) | -14.11% |
| Return on Capital Employed (ROCE) | -24.13% |
| Revenue Per Employee | 2.41M |
| Profits Per Employee | -1.65M |
| Employee Count | 107 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.58% in the last 52 weeks. The beta is -0.26, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.26 |
| 52-Week Price Change | +8.58% |
| 50-Day Moving Average | 207.68 |
| 200-Day Moving Average | 191.98 |
| Relative Strength Index (RSI) | 62.79 |
| Average Volume (20 Days) | 360,364 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 257.35 million and -177.08 million in losses. Loss per share was -2.00.
| Revenue | 257.35M |
| Gross Profit | 230.37M |
| Operating Income | -225.88M |
| Pretax Income | -189.52M |
| Net Income | -177.08M |
| EBITDA | -207.45M |
| EBIT | -225.88M |
| Loss Per Share | -2.00 |
Balance Sheet
The company has 512.93 million in cash and 54.23 million in debt, giving a net cash position of 458.70 million or 5.19 per share.
| Cash & Cash Equivalents | 512.93M |
| Total Debt | 54.23M |
| Net Cash | 458.70M |
| Net Cash Per Share | 5.19 |
| Equity (Book Value) | 894.94M |
| Book Value Per Share | 10.13 |
| Working Capital | 835.00M |
Cash Flow
| Operating Cash Flow | -316.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 89.51%, with operating and profit margins of -87.77% and -68.81%.
| Gross Margin | 89.51% |
| Operating Margin | -87.77% |
| Pretax Margin | -73.64% |
| Profit Margin | -68.81% |
| EBITDA Margin | -80.61% |
| EBIT Margin | -87.77% |
| FCF Margin | n/a |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | -0.82% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |